ArriVent BioPharma

AVBPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.436 B

$30.84 -0.55%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$166.3M

Loss-making

Shares outstanding

44,201,622

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#139Avalyn PharmaAVLN$1.50B
#140InnovivaINVA$1.48B
#141ArriVent BioPharmaAVBP$1.44B
#142Oric PharmaceuticalsORIC$1.40B
#143Phibro Animal HealthPAHC$1.39B

Where these numbers come from

Share counts and financials for ArriVent BioPharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.